Virtu Financial LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 294 filers reported holding NEKTAR THERAPEUTICS in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q2 2023$8
-78.4%
13,675
-16.6%
0.00%
-80.0%
Q4 2022$37
-100.0%
16,394
-29.5%
0.01%
-89.8%
Q4 2019$502,000
+19.8%
23,260
+97.5%
0.05%
+96.0%
Q2 2019$419,000
+46.0%
11,780
-48.6%
0.02%
-3.8%
Q2 2015$287,000
+50.3%
22,907
+44.6%
0.03%
+30.0%
Q3 2014$191,00015,8400.02%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2019
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders